Clinical Predictors of 3-Months Isoniazid Rifapentine (3HP) - Related Adverse Drug Reactions (ADR) During Tuberculosis Preventive Therapy. (PAnDoRA-3HP study): An Observational Study Protocol.
Sekaggya-Wiltshire C, Mbabazi I, Nabisere-Arinaitwe R, Banturaki G, Alinaitwe L, Otalo B, Aber F, Nampala J, Owor R, Bayiga J, Laker Agnes Odongpiny E, Castelnuovo B, Mayito J, Sekadde M, Pasipanodya JG, Turyahabwe S, Zawedde-Muyanja S.
Sekaggya-Wiltshire C, et al. Among authors: castelnuovo b.
medRxiv [Preprint]. 2024 Jun 2:2024.06.01.24308310. doi: 10.1101/2024.06.01.24308310.
medRxiv. 2024.
PMID: 38853861
Free PMC article.
Updated.
Preprint.